Nachrichten zur CRISPR Therapeutics AG Aktie

Crispr Therapeutics Aktie: Positive Schlagzeilen

Die Führungsriege des Gentechnik-Unternehmens Crispr Therapeutics sorgte kürzlich mit umfangreichen Aktienverkäufen für Aufsehen an der Börse. Der Vorstandsvorsitzende trennte sich…

AKTIONÄR-Depotwert CRISPR Therapeutics: Plus 34 Prozent in einer Woche – geht die Aufholjagd weiter?

Der Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics scheint die Initialzündung gelungen zu sein. Nachdem die Aktie bereits in den vergangenen Tagen…

AKTIONÄR-Depotwert CRISPR Therapeutics: Plus 34 Prozent in einer Woche – geht die Aufholjagd weiter?

Der Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics scheint die Initialzündung gelungen zu sein. Nachdem die Aktie bereits in den vergangenen Tagen…

AKTIONÄR-Depotwert CRISPR Therapeutics: Aktie mit Kurssprung – spannendes Jahr voraus

Lange Zeit war es ruhig um die Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics. In der vergangenen Woche hat sich das Papier…

AKTIONÄR-Depotwert CRISPR Therapeutics: Aktie mit Kurssprung – spannendes Jahr voraus

Lange Zeit war es ruhig um die Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics. In der vergangenen Woche hat sich das Papier…

AKTIONÄR-Depotwert CRISPR Therapeutics: Aktie mit Kurssprung - spannendes Jahr voraus

Lange Zeit war es ruhig um die Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics. In der vergangenen Woche hat sich das Papier…

CRISPR Therapeutics Aktie: Kursrally dank Analysten-Upgrade?

Kulmbach (www.aktiencheck.de) - CRISPR Therapeutics-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie der CRISPR Therapeutics AG…

AKTIONÄR-Depotwert CRISPR Therapeutics: "Neue Ära" – Kursziel 99 Dollar!

Mit einem vorbörslichen Kursplus von gut fünf Prozent kann die Aktie von CRISPR Therapeutics an die bisherige starke Wochenperformance anknüpfen.…

AKTIONÄR-Depotwert CRISPR Therapeutics: "Neue Ära" – Kursziel 99 Dollar!

Mit einem vorbörslichen Kursplus von gut fünf Prozent kann die Aktie von CRISPR Therapeutics an die bisherige starke Wochenperformance anknüpfen.…

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

On Hump Day, investors piled into CRISPR Therapeutics (NASDAQ: CRSP) stock, sending its price more than 9% higher at the…

CRISPR Therapeutics: Cathie Woods große Hoffnung

Seit mehr als sieben Jahren ist die US-Investorin Cathie Wood an dem Schweizer Pharmakonzern CRISPR Therapeutics beteiligt. Im vorangegangenen Quartal…

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 61.74% and 252.50%, respectively, for the quarter ended December 2024. Do…

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $39.41 in the latest trading session, marking a -0.76% move from the prior day.…

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Investing in stocks that arent performing well can be a good move, but only if there are good reasons to…

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

…

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $40.49, marking a +1.23% move from the previous day.…

My Top 5 Stocks to Buy in Early 2025

Its the start of a new year, and that makes now the perfect time to load up on stocks that…

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this…

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

…

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

If youre an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech…

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

Whats going on with CRISPR Therapeutics (NASDAQ: CRSP)? The companys shares have been southbound for the better part of three…

2 Unstoppable Stocks to Buy and Hold for the Next Decade

What do Apple (NASDAQ: AAPL) and Vertex Pharmaceuticals (NASDAQ: VRTX) have in common? At first glance, not much. The former…

CRISPR Therapeutics Aktie: Cathie Wood stockt ihre Position auf

Kulmbach (www.aktiencheck.de) - CRISPR Therapeutics-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there are…

3 Things You Need to Know if You Buy CRISPR Therapeutics Today

CRISPR Therapeutics (NASDAQ: CRSP) is recognized as a pioneer in the field of gene therapy. This biotechnology has the potential…

CRISPR Therapeutics stock hits 52-week low at $43.37 By Investing.com

CRISPR Therapeutics stock hits 52-week low at $43.37…

3 of the Best Growth Stocks You Can Buy for Less than $100

Its getting harder these days to find great growth stocks trading for less than $100 a share. It almost seems…

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. This…

3 Monster Stocks in the Making

Godzilla and King Kong surely werent born big. They began small and grew over time to their gargantuan sizes even…

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

…

CRISPR Therapeutics (NASDAQ:CRSP) shareholders have endured a 59% loss from investing in the stock three years ago

If you love investing in stocks youre bound to buy some losers. Long term CRISPR Therapeutics AG ( NASDAQ:CRSP...…

[Latest] Global Genetic Engineering Market Size/Share Worth USD 2,917.2 Million by 2033 at a 6.74% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

dpa-AFX ProFeed